Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 74 Records) |
| Query Trace: Disease and HSD17B13[original query] |
|---|
| Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort. Hepatology communications 2021 Jun . Wang Jun, Conti David V, Bogumil David, Sheng Xin, Noureddin Mazen, Wilkens Lynne R, Le Marchand Loic, Rosen Hugo R, Haiman Christopher A, Setiawan Veronica Wen |
| The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD. Clinical and translational gastroenterology 2021 Sep 12 (9): e00400. Vilar-Gomez Eduardo, Pirola Carlos J, Sookoian Silvia, Wilson Laura A, Liang Tiebing, Chalasani Na |
| Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis. BMC gastroenterology 2021 12 21 (1): 490. Tang Shan, Zhang Jing, Mei Ting-Ting, Zhang Wen-Yan, Zheng Su-Jun, Yu Hai-B |
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.
The Lancet. Oncology 2021 12 23 (1): 161-171. Trépo Eric, Caruso Stefano, Yang Jie, Imbeaud Sandrine, Couchy Gabrielle, Bayard Quentin, Letouzé Eric, Ganne-Carrié Nathalie, Moreno Christophe, Oussalah Abderrahim, Féray Cyrille, Blanc Jean Frédéric, Clément Bruno, Hillon Patrick, Boursier Jérôme, Paradis Valérie, Calderaro Julien, Gnemmi Viviane, Nault Jean-Charles, Guéant Jean-Louis, Devière Jacques, Archambeaud Isabelle, Vitellius Carole, Turlin Bruno, Bronowicki Jean-Pierre, Gustot Thierry, Sutton Angela, , Ziol Marianne, Nahon Pierre, Zucman-Rossi Jessi |
| A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. Journal of hepatology 2021 10 76 (2): 275-282. Whitfield John B, Schwantes-An Tae-Hwi, Darlay Rebecca, Aithal Guruprasad P, Atkinson Stephen R, Bataller Ramon, Botwin Greg, Chalasani Naga P, Cordell Heather J, Daly Ann K, Day Christopher P, Eyer Florian, Foroud Tatiana, Gleeson Dermot, Goldman David, Haber Paul S, Jacquet Jean-Marc, Liang Tiebing, Liangpunsakul Suthat, Masson Steven, Mathurin Philippe, Moirand Romain, McQuillin Andrew, Moreno Christophe, Morgan Marsha Y, Mueller Sebastian, Müllhaupt Beat, Nagy Laura E, Nahon Pierre, Nalpas Bertrand, Naveau Sylvie, Perney Pascal, Pirmohamed Munir, Seitz Helmut K, Soyka Michael, Stickel Felix, Thompson Andrew, Thursz Mark R, Trépo Eric, Morgan Timothy R, Seth Devanshi, |
| Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience 2022 9 25 (9): 104949. Sen Partho, Govaere Olivier, Sinioja Tim, McGlinchey Aidan, Geng Dawei, Ratziu Vlad, Bugianesi Elisabetta, Schattenberg Jörn M, Vidal-Puig Antonio, Allison Michael, Cockell Simon, Daly Ann K, Hyötyläinen Tuulia, Anstee Quentin M, Oreši? Mat |
| Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study. Hepatology international 2022 Jul . Yang Aruhan, Zhu Xiaoxue, Zhang Lei, Zhang Yingwen, Zhang Dezhi, Jin Meishan, Niu Junqi, Zhang Huimao, Ding Yanhua, Lv Guoy |
| Contribution of a genetic risk score to ethnic differences in fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 2022 5 42 (10): 2227-2236. Kubiliun Maddie J, Cohen Jonathan C, Hobbs Helen H, Kozlitina Jul |
| Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Hepatology communications 2022 4 6 (8): 1934-1948. Hudert Christian A, Adams Leon A, Alisi Anna, Anstee Quentin M, Crudele Annalisa, Draijer Laura G, Furse Samuel, Hengstler Jan G, Jenkins Benjamin, Karnebeek Kylie, Kelly Deirdre A, Koot Bart G, Koulman Albert, Meierhofer David, Melton Phillip E, Mori Trevor A, Snowden Stuart G, van Mourik Indra, Vreugdenhil Anita, Wiegand Susanna, Mann Jake P, |
| MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery. International journal of molecular sciences 2022 12 23 (24): . Kalinowski Piotr, Smyk Wiktor, Nowosad Ma?gorzata, Paluszkiewicz Rafa?, Micha?owski ?ukasz, Ziarkiewicz-Wróblewska Bogna, Weber Susanne N, Milkiewicz Piotr, Lammert Frank, Zieniewicz Krzysztof, Krawczyk Marc |
| Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients. International journal of molecular sciences 2022 10 23 (19): . Gil-Gómez Antonio, Rojas Ángela, García-Lozano María R, Muñoz-Hernández Rocío, Gallego-Durán Rocío, Maya-Miles Douglas, Montero-Vallejo Rocío, Gato Sheila, Gallego Javier, Francés Rubén, Soriano Germán, Ampuero Javier, Romero-Gómez Manu |
| The influence of host genetics on liver microbiome composition in patients with NAFLD. EBioMedicine 2022 Feb 76 103858. Pirola Carlos Jose, Salatino Adrian, Quintanilla Maria Florencia, Castaño Gustavo Osvaldo, Garaycoechea Martin, Sookoian Silv |
| Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants. International journal of molecular sciences 2023 9 24 (17): . Lanuza A P Faccioli, Zeliha Cetin, Zehra N Kocas-Kilicarslan, Kimberly Ortiz, Yiyue Sun, Zhiping Hu, Takeshi Kurihara, Edgar N Tafaleng, Rodrigo M Florentino, Zi Wang, Mengying Xia, Mark T Miedel, D Lansing Taylor, Jaideep Behari, Alina Ostrowska, Robert Constantine, Albert Li, Alejandro Soto-Gutierr |
| Impact of genetic polymorphism to personalized diet and exercise program for steatotic liver disease. Hepatology research : the official journal of the Japan Society of Hepatology 2023 9 . Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, Kenichi Nakamichi, Eiji Saegusa, Hidetoshi Ogura, Masaki Kato, Etsuko Doi, Naoko Inoue, Hitomi Sezaki, Tetsuya Hosaka, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Yoshiyuki Suzuki, Hiromitsu Kumada, Fumitaka Suzu |
| Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort. Gut and liver 2023 8 . Huiyul Park, Eileen L Yoon, Goh Eun Chung, Eun Kyung Choe, Jung Ho Bae, Seung Ho Choi, Mimi Kim, Woochang Hwang, Hye-Lin Kim, Sun Young Yang, Dae Won J |
| Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization study. Liver international : official journal of the International Association for the Study of the Liver 2023 6 . Helene Gellert-Kristensen, Anne Tybjaerg-Hansen, Børge G Nordestgaard, Jonas Ghouse, Andreas Fuchs, Jørgen T Kühl, Per E Sigvardsen, Klaus F Kofoed, Stefan Stend |
| Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease. Metabolites 2023 2 13 (2): . Fernandes Silva Lilian, Vangipurapu Jagadish, Oravilahti Anniina, Männistö Ville, Laakso Mark |
| Comparing rare variants versus common in the pathogenesis of nonalcoholic fatty liver disease: a whole exome sequencing approach. Journal of gastroenterology and hepatology 2023 11 . Govardhan Bale, Anand V Kulkarni, Nagaraja Rao Padaki, P Balachandran Menon, Mithun Sharma, Sowmya Iyengar, Anuradha Sekaran, Smita C Pawar, Nageshwar Reddy Duvvur, Ravikanth Vishnubhot |
| Rare variant associations with plasma protein levels in the UK Biobank. Nature 2023 10 622 (7982): 339-347. Ryan S Dhindsa, Oliver S Burren, Benjamin B Sun, Bram P Prins, Dorota Matelska, Eleanor Wheeler, Jonathan Mitchell, Erin Oerton, Ventzislava A Hristova, Katherine R Smith, Keren Carss, Sebastian Wasilewski, Andrew R Harper, Dirk S Paul, Margarete A Fabre, Heiko Runz, Coralie Viollet, Benjamin Challis, Adam Platt, , Dimitrios Vitsios, Euan A Ashley, Christopher D Whelan, Menelas N Pangalos, Quanli Wang, Slavé Petrovs |
| Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 1 . Rutledge Stephanie M, Soper Emily R, Ma Ning, Pejaver Vikas, Friedman Scott L, Branch Andrea D, Kenny Eimear E, Belbin Gillian M, Abul-Husn Noura |
| Liver phenotypes in PCOS: Analysis of exogenous and inherited risk factors for liver injury in two European cohorts. Liver international : official journal of the International Association for the Study of the Liver 2023 1 . Smyk Wiktor, Papapostoli Ifigeneia, ?orniak Micha?, Sklavounos Panagiotis, Blukacz ?ukasz, Madej Pawe?, Koutsou Andreani, Weber Susanne N, Friesenhahn-Ochs Bettina, Cebula Maciej, Bosowska Joanna, Solomayer Erich-Franz, Hartleb Marek, Milkiewicz Piotr, Lammert Frank, Stokes Caroline S, Krawczyk Marc |
| Combination of risk alleles of PNPLA3, TM6SF2, and HSD17B13 of donors can predict recurrence of steatotic liver disease after liver transplantation. Hepatology research : the official journal of the Japan Society of Hepatology 2024 7 . Kenta Makino, Takamichi Ishii, Satoshi Ogiso, Akiyoshi Nakakura, Takahiro Nishio, Ken Fukumitsu, Elena Yukie Uebayashi, Fumiaki Munekage, Hiroshi Horie, Kentaro Iwaki, Takashi Ito, Etsuro Hata |
| Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B? Journal of gastrointestinal and liver diseases : JGLD 2024 6 33 (2): 203-211. Coskun Ozer Demirtas, Fatih Eren, Demet Yilmaz, Osman Cavit Ozdogan, Feyza Gund |
| The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 2024 6 . Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Rohit Loomba, Veeral Ajme |
| Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and research in hepatology and gastroenterology 2024 6 48 (7): 102389. Elias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, Mira Thing, Puria Nabilou, Nina Kimer, Anders Ellekaer Junker, Anne-Sofie Houlberg Jensen, Børge Grønne Nordestgaard, Stefan Stender, Lise Lotte Glu |
| Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. Nutrients 2024 6 16 (12): . Nantawat Satthawiwat, Thananya Jinato, Sawannee Sutheeworapong, Natthaporn Tanpowpong, Natthaya Chuaypen, Pisit Tangkijvani |
| Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. American journal of biological anthropology 2024 5 e24979. Maria C Rieman-Klingler, Jinho Jung, Kaleb Tesfai, Rohit Loomba, Amy L N |
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. Genes 2024 4 15 (4): . Nehal Elmansoury, Ahmed A Megahed, Ahmed Kamal, Nefertiti El-Nikhely, Marina Labane, Manal Abdelmageed, Ann K Daly, Ahmed Wah |
| Differential effects of genetic polymorphism on comorbid disease in metabolic dysfunction-associated steatotic liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 4 . Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Takeshi Okanoue, Yoshito It |
| Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study. EClinicalMedicine 2024 1 67 102350. Julia Kozlitina, Naomi M Cohen, Drew Sturtevant, Jonathan C Cohen, Cathi Murphey-Half, Jerome G Saltarrelli, Peter Jindra, Medhat Askar, Christine S Hwang, Parsia A Vagefi, Chantale Lacelle, Helen H Hobbs, Malcolm P MacConma |
- Page last reviewed:Feb 1, 2024
- Content source: